These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 403278)

  • 41. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical pharmacokinetics of quinidine.
    Ochs HR; Greenblatt DJ; Woo E
    Clin Pharmacokinet; 1980; 5(2):150-68. PubMed ID: 6988137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninteraction of digitoxin and quinidine.
    Ochs HR; Pabst J; Greenblatt DJ; Dengler HJ
    N Engl J Med; 1980 Sep; 303(12):672-4. PubMed ID: 7402253
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of cimetidine on quinidine distribution in rats.
    Shibasaki S; Komoriya K; Gon S; Matsuura Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1987 Dec; 10(12):719-26. PubMed ID: 3451957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quinidine-rifampin interaction.
    Twum-Barima Y; Carruthers SG
    N Engl J Med; 1981 Jun; 304(24):1466-9. PubMed ID: 7231477
    [No Abstract]   [Full Text] [Related]  

  • 46. Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol.
    Kessler KM; Humphries WC; Black M; Spann JF
    Am Heart J; 1978 Nov; 96(5):627-35. PubMed ID: 263396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic properties of ethosuximide in monkeys. II. Chronic intravenous and oral administration.
    Patel IH; Levy RH
    Epilepsia; 1975 Dec; 16(5):717-30. PubMed ID: 816645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
    Fremstad D; Jacobsen S; Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):161-76. PubMed ID: 579055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine.
    Edwards DJ; Lavoie R; Beckman H; Blevins R; Rubenfire M
    Clin Pharmacol Ther; 1987 Jan; 41(1):68-73. PubMed ID: 3802708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.
    Iven H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):43-50. PubMed ID: 882146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digitoxin-quinidine interaction: pharmacokinetic evaluation.
    Fenster PE; Powell JR; Graves PE; Conrad KA; Hager WD; Goldman S; Marcus FI
    Ann Intern Med; 1980 Nov; 93(5):698-701. PubMed ID: 7212478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disposition of intravenous propylthiouracil.
    Giles HG; Roberts EA; Orrego H; Sellers EM
    J Clin Pharmacol; 1981; 21(11):466-71. PubMed ID: 7334138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acebutolol disposition after intravenous administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers.
    Munafo A; Buclin T; Tuto D; Biollaz J
    Eur J Clin Pharmacol; 1992; 43(4):441-3. PubMed ID: 1451729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits.
    Ueda CT; Nickols JG
    J Pharm Sci; 1980 Dec; 69(12):1400-3. PubMed ID: 7463324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of disposition parameters of quinidine and quinine in the rat.
    Watari N; Wakamatsu A; Kaneniwa N
    J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.